Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
Avenue Therapeutics, Inc. (ATXI)
Today's Latest Price: $10.39 USD
0.11 (-1.05%)
Updated Feb 18 8:00pm
Add ATXI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATXI Daily Price Range
ATXI 52-Week Price Range
ATXI Stock Price Chart More Charts
ATXI Price/Volume Stats
| Current price | $10.39 | 52-week high | $11.47 |
| Prev. close | $10.50 | 52-week low | $4.13 |
| Day low | $10.20 | Volume | 48,200 |
| Day high | $10.75 | Avg. volume | 49,694 |
| 50-day MA | $8.87 | Dividend yield | N/A |
| 200-day MA | $6.54 | Market Cap | 173.11M |
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
Top Stories View All
Best & Worst Performing Stock Industries for February 18, 2020
Best & Worst Performing Small Cap Stocks for February 18, 2020
Best & Worst Performing Mid Cap Stocks for February 18, 2020
Best & Worst Performing Large Cap Stocks for February 18, 2020
Best & Worst Performing Mega Cap Stocks for February 18, 2020
View All Top Stories
Loading social stream, please wait...